Related Experiment Video
Updated: Aug 7, 2026

Expression, Isolation, and Purification of Soluble and Insoluble Biotinylated Proteins for Nerve Tissue Regeneration
Published on: January 22, 2014
Effective expression and purification of recombinant onconase, an antitumor protein
E Notomista1, V Cafaro, R Fusiello
1Dipartimentó di Chimica Organica e Biologica, Università di Napoli Federico II, Via Mezzocannone 16, 80134, Naples, Italy.
Abstract:
Several members of the RNase A superfamily are endowed with antitumor activity, showing selective cytotoxicity toward several tumor cell lines. One of these is onconase, the smallest member of the RNase A superfamily, which is at present undergoing phase III clinical trials. We report here the expression of recombinant onconase in Escherichia coli inclusion bodies, the correct processing of the protein, followed by its purification in high yields. The recombinant protein has biological and catalytic properties identical to those of the natural enzyme.
Insights
Researchers successfully produced recombinant onconase, an antitumor enzyme, in bacteria. This engineered onconase exhibits identical biological and catalytic properties to the natural enzyme, supporting its therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The RNase A superfamily contains enzymes with antitumor properties.
- Onconase, the smallest RNase A member, shows selective cytotoxicity against tumor cells and is in clinical trials.
Purpose of the Study:
- To express and purify recombinant onconase in Escherichia coli.
- To confirm the biological and catalytic identity of the recombinant protein compared to the natural enzyme.
Main Methods:
- Expression of recombinant onconase in E. coli inclusion bodies.
- Protein processing and purification techniques.
- Assessment of biological and catalytic activity.
Main Results:
- High yields of correctly processed recombinant onconase were obtained.
- The recombinant onconase demonstrated identical biological and catalytic properties to the natural enzyme.
Conclusions:
- Recombinant onconase can be efficiently produced with preserved functionality.
- This production method supports further development and clinical application of onconase as an antitumor agent.

